Idexx Laboratories Inc
Idexx Laboratories
IDXX · NASDAQ
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $4.3B
- Assets
- $3.4B
- SEC filing
- DEF 14A
- Filed
- March 27, 2026
Executive Compensation
Compensation reported for Idexx Laboratories’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Jonathan J. Mazelsky
President And Chief Executive Officer
$14.6M
Reported total
- Salary
- $1,150,000
- Stock awards
- $5,399,881
- Incentives
- $2,593,000
- Option awards
- $5,400,001
- Other
- $37,240
Michael J. Lane
Executive Vice President And General Manager, Cag Diagnostics Business Unit
$4M
Reported total
- Salary
- $594,054
- Stock awards
- $1,349,855
- Incentives
- $627,270
- Option awards
- $1,349,949
- Other
- $98,288
Tina Hunt Ph DExecutive
Vice President, Global Strategy And Commercial
$3.9M
Reported total
- Salary
- $594,054
- Stock awards
- $1,349,855
- Incentives
- $627,270
- Option awards
- $1,349,949
- Other
- $24,165
Martin Smith Ph
D Executive Vice President And Chief Technology Officer, R&d, Global Operations, Information Technology And Information Security
$3.9M
Reported total
- Salary
- $594,054
- Stock awards
- $1,349,855
- Incentives
- $627,270
- Option awards
- $1,349,949
- Other
- $23,406
Andrew Emerson
Executive Vice President And Chief Financial Officer
$3M
Reported total
- Salary
- $531,146
- Stock awards
- $949,864
- Incentives
- $577,500
- Option awards
- $949,941
- Other
- $24,620
Brian P. McKeon
Former Executive Vice President, Chief Financial Officer And Treasurer
$352K
Reported total
- Salary
- $293,404
- Stock awards
- $0
- Incentives
- $0
- Option awards
- $0
- Other
- $58,276
Jonathan J. Mazelsky
President And Chief Executive Officer
$14.6M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 27, 2026.
- Salary
- $1.1M
- Stock Awards
- $5.4M
- Option Awards
- $5.4M
- Incentives
- $2.6M
- Other
- $37K
Historical Compensation
Jonathan J. Mazelsky total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,150,000 | $5,399,881 | $14,580,122 |
| 2024 | $1,121,154 | $5,199,755 | $13,007,051 |
| 2023 | $1,000,000 | $2,187,697 | $11,519,309 |
Named Executive Officers
Jonathan J. Mazelsky
President And Chief Executive Officer
Idexx Laboratories · IDXX
$14.6M
FY 2025 · DEF 14A
Andrew Emerson
Executive Vice President And Chief Financial Officer
Idexx Laboratories · IDXX
$3M
FY 2025 · DEF 14A
Michael J. Lane
Executive Vice President And General Manager, Cag Diagnostics Business Unit
Idexx Laboratories · IDXX
$4M
FY 2025 · DEF 14A
Tina Hunt Ph DExecutive
Vice President, Global Strategy And Commercial
Idexx Laboratories · IDXX
$3.9M
FY 2025 · DEF 14A
Martin Smith Ph
D Executive Vice President And Chief Technology Officer, R&d, Global Operations, Information Technology And Information Security
Idexx Laboratories · IDXX
$3.9M
FY 2025 · DEF 14A
Brian P. McKeon
Former Executive Vice President, Chief Financial Officer And Treasurer
Idexx Laboratories · IDXX
$352K
FY 2025 · DEF 14A
Source information
- Company
- Idexx Laboratories Inc
- Ticker
- IDXX · NASDAQ
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 27, 2026
- SEC accession number
- 0000874716-26-000064
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →